These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

563 related articles for article (PubMed ID: 16838179)

  • 1. Regulatory T cells and innate immune regulation in tumor immunity.
    Wang RF
    Springer Semin Immunopathol; 2006 Aug; 28(1):17-23. PubMed ID: 16838179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulatory T cells and Toll-like receptors in tumor immunity.
    Wang RF; Peng G; Wang HY
    Semin Immunol; 2006 Apr; 18(2):136-42. PubMed ID: 16469504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD8+ regulatory T cells, their suppressive mechanisms, and regulation in cancer.
    Wang RF
    Hum Immunol; 2008 Nov; 69(11):811-4. PubMed ID: 18817828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional control of regulatory T cells and cancer immunotherapy.
    Wang RF
    Semin Cancer Biol; 2006 Apr; 16(2):106-14. PubMed ID: 16423537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toll-like receptors and immune regulation: their direct and indirect modulation on regulatory CD4+ CD25+ T cells.
    Liu G; Zhao Y
    Immunology; 2007 Oct; 122(2):149-56. PubMed ID: 17848162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulatory T cells and cancer.
    Wang HY; Wang RF
    Curr Opin Immunol; 2007 Apr; 19(2):217-23. PubMed ID: 17306521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toll-like receptors and immune regulation: implications for cancer therapy.
    Wang RF; Miyahara Y; Wang HY
    Oncogene; 2008 Jan; 27(2):181-9. PubMed ID: 18176599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulatory T cells and toll-like receptors in cancer therapy.
    Wang RF
    Cancer Res; 2006 May; 66(10):4987-90. PubMed ID: 16707417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TLR ligand suppression or enhancement of Treg cells? A double-edged sword in immunity to tumours.
    Conroy H; Marshall NA; Mills KH
    Oncogene; 2008 Jan; 27(2):168-80. PubMed ID: 18176598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toll-like receptor signalling on Tregs: to suppress or not to suppress?
    van Maren WW; Jacobs JF; de Vries IJ; Nierkens S; Adema GJ
    Immunology; 2008 Aug; 124(4):445-52. PubMed ID: 18540962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Graded Foxo1 activity in Treg cells differentiates tumour immunity from spontaneous autoimmunity.
    Luo CT; Liao W; Dadi S; Toure A; Li MO
    Nature; 2016 Jan; 529(7587):532-6. PubMed ID: 26789248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of T cell activation by TLR ligands.
    Oberg HH; Juricke M; Kabelitz D; Wesch D
    Eur J Cell Biol; 2011; 90(6-7):582-92. PubMed ID: 21292344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-derived γδ regulatory T cells suppress innate and adaptive immunity through the induction of immunosenescence.
    Ye J; Ma C; Hsueh EC; Eickhoff CS; Zhang Y; Varvares MA; Hoft DF; Peng G
    J Immunol; 2013 Mar; 190(5):2403-14. PubMed ID: 23355732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-infiltrating gammadelta T cells suppress T and dendritic cell function via mechanisms controlled by a unique toll-like receptor signaling pathway.
    Peng G; Wang HY; Peng W; Kiniwa Y; Seo KH; Wang RF
    Immunity; 2007 Aug; 27(2):334-48. PubMed ID: 17656116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune suppression by tumor-specific CD4+ regulatory T-cells in cancer.
    Wang RF
    Semin Cancer Biol; 2006 Feb; 16(1):73-9. PubMed ID: 16140545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulatory T cells and Toll-like receptors: what is the missing link?
    Dai J; Liu B; Li Z
    Int Immunopharmacol; 2009 May; 9(5):528-33. PubMed ID: 19539562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotypic and Functional Properties of Tumor-Infiltrating Regulatory T Cells.
    Lee GR
    Mediators Inflamm; 2017; 2017():5458178. PubMed ID: 29463952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Toll-like receptor-driven innate immunity in thoracic organ transplantation.
    Goldstein DR; Palmer SM
    J Heart Lung Transplant; 2005 Nov; 24(11):1721-9. PubMed ID: 16297771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms and pathways of innate immune activation and regulation in health and cancer.
    Cui J; Chen Y; Wang HY; Wang RF
    Hum Vaccin Immunother; 2014; 10(11):3270-85. PubMed ID: 25625930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role for the cAMP-protein kinase A signaling pathway in suppression of antitumor immune responses by regulatory T cells.
    Yaqub S; Taskén K
    Crit Rev Oncog; 2008; 14(1):57-77. PubMed ID: 19105570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.